Gabapentin
- Product NDC
- 51224-019
- 11-digit product format
- 512240019
- Labeler code
- 51224
- Product ID
- 51224-019_7df72914-16b4-46c8-b04c-e68bdc664300
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- TAGI Pharma, Inc.
- Application
- ANDA075477
- Marketing category
- ANDA
- Marketing start
- 2020-01-01
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51224-019-50 | 51224001950 | 100 CAPSULE in 1 BOTTLE (51224-019-50) | 100 capsule | 2020-01-01 | 0000-00-00 | No | No | Current |
| 51224-019-60 | 51224001960 | 500 CAPSULE in 1 BOTTLE (51224-019-60) | 500 capsule | 2020-01-01 | 0000-00-00 | No | No | Current |
| 51224-019-70 | 51224001970 | 1000 CAPSULE in 1 BOTTLE (51224-019-70) | 1000 capsule | 2020-01-01 | 0000-00-00 | No | No | Current |